CENTURION PHARMA

Centurion Pharma began in 1949 as a Turkish pharmaceutical company importing, distributing and promoting niche generic products in Istanbul, later establishing a state-of-the-art manufacturing facility in Ankara in 2016 capable of producing sterile injectable, biological and niche generic products. The company's specialized portfolio focuses on rare and chronic diseases across anti-infectives, analgesics, anti-fungals, osteoporosis products, biological plasma products, vaccines and biosimilars, with significant R&D investment over the past 9 years and an EU GMP certificate received in December 2021, exporting to a wide range of countries.